Skip to main content

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. NCR-National Cancer Registry of The Netherlands (2013) Cancer in the Netherlands – online data registry. Vereniging Integrale Kankercentra, Utrecht. www.cancerregistry.nl

  2. de Vries E, Houterman S, Janssen-Heijnen ML, Nijsten T, van de Schans SA, Eggermont AM, Coebergh JW (2007) Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol 18(6):1110–1116

    Article  PubMed  Google Scholar 

  3. Friedman RJ, Rigel DS, Kopf AW (1985) Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin 35(3):130–151

    Article  CAS  PubMed  Google Scholar 

  4. Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, Kopf AW, Polsky D (2004) Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 292(22):2771–2776

    Article  CAS  PubMed  Google Scholar 

  5. Chamberlain AJ, Fritschi L, Kelly JW (2003) Nodular melanoma: patients’ perceptions of presenting features and implications for earlier detection. J Am Acad Dermatol 48(5):694–701

    Article  PubMed  Google Scholar 

  6. Rofstad EK, Brustad T (1985) Tumour growth delay following single dose irradiation of human melanoma xenografts. Correlations with tumour growth parameters, vascular structure and cellular radiosensitivity. Br J Cancer 51(2):201–210

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Bentzen SM, Overgaard J, Thames HD, Overgaard M, Vejby Hansen P, von der Maase H, Meder J (1989) Clinical radiobiology of malignant melanoma. Radiother Oncol 16(3):169–182

    Article  CAS  PubMed  Google Scholar 

  8. Bentzen SM, Thames HD, Overgaard J (1990) Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma? Int J Radiat Biol 57(1):117–126

    Article  CAS  PubMed  Google Scholar 

  9. Sause WT, Cooper JS, Rush S, Ago CT, Cosmatos D, Coughlin CT, JanJan N, Lipsett J (1991) Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 20(3):429–432

    Article  CAS  PubMed  Google Scholar 

  10. Corry J, Smith JG, Bishop M, Ainslie J (1999) Nodal radiation therapy for metastatic melanoma. Int J Radiat Oncol Biol Phys 44(5):1065–1069

    Article  CAS  PubMed  Google Scholar 

  11. Fenig E, Eidelevich E, Njuguna E, Katz A, Gutman H, Sulkes A, Schechter J (1999) Role of radiation therapy in the management of cutaneous malignant melanoma. Am J Clin Oncol 22(2):184–186

    Article  CAS  PubMed  Google Scholar 

  12. Burmeister BH, Mark Smithers B, Burmeister E, Baumann K, Davis S, Krawitz H, Johnson C, Spry N, Trans Tasman Radiation Oncology Group (2006) A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiother Oncol 81(2):136–142

    Article  PubMed  Google Scholar 

  13. Chang DT, Amdur RJ, Morris CG, Mendenhall WM (2006) Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys 66(4):1051–1055

    Article  PubMed  Google Scholar 

  14. Strojan P, Jancar B, Cemazar M, Perme MP, Hocevar M (2010) Melanoma metastases to the neck nodes: role of adjuvant irradiation. Int J Radiat Oncol Biol Phys 77(4):1039–1045

    Article  PubMed  Google Scholar 

  15. Harwood AR, Cummings BJ (1981) Radiotherapy for malignant melanoma: a re-appraisal. Cancer Treat Rev 8:271–282

    Article  CAS  PubMed  Google Scholar 

  16. Trott KR (1991) The optimal radiation dose per fraction for treatment of malignant melanomas. Int J Radiat Oncol Biol Phys 20:905–907

    Article  CAS  PubMed  Google Scholar 

  17. Gojkovič-Horvat A, Jančar B, Blas M, Zumer B, Karner K, Hočevar M, Strojan P (2012) Adjuvant radiotherapy for palpable melanoma metastases to the groin: when to irradiate? Int J Radiat Oncol Biol Phys 83(1):310–316

    Article  PubMed  Google Scholar 

  18. Bastiaannet E, Beukema JC, Hoekstra HJ (2005) Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev 31(1):18–26

    Article  CAS  PubMed  Google Scholar 

  19. Seegenschmiedt MH, Keilholz L, Altendorf-Hofmann A, Urban A, Schell H, Hohenberger W, Sauer R (1999) Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. Int J Radiat Oncol Biol Phys 44(3):607–618

    Article  CAS  PubMed  Google Scholar 

  20. Hulshof MC, Van Haaren PM, Zum Vörde Sive Vörding PJ, Krishnadath S, Marsman WA, Van Berge Henegouwen MI, Geijsen ED, Crezee J (2010) Radiotherapy combined with hyperthermia for primary malignant melanomas of the esophagus. Dis Esophagus 23(8):E42–E47

    Article  CAS  PubMed  Google Scholar 

  21. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM (2009) Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996. Int J Hyperthermia 25(5):323–334

    Article  CAS  PubMed  Google Scholar 

  22. Douglas JG, Margolin K (2002) The treatment of brain metastases from malignant melanoma. Semin Oncol 29(5):518–524

    Article  PubMed  Google Scholar 

  23. Staudt M, Lasithiotakis K, Leiter U, Meier F, Eigentler T, Bamberg M, Tatagiba M, Brossart P, Garbe C (2010) Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer 102(8):1213–1218

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Koomen ER, de Vries E, van Kempen LC, van Akkooi AC, Guchelaar HJ, Louwman MW, Nijsten T, Coebergh JW (2010) Epidemiology of extracutaneous melanoma in the Netherlands. Cancer Epidemiol Biomarkers Prev 19(6):1453–1459

    Article  PubMed  Google Scholar 

  25. Damato B (2006) Treatment of primary intraocular melanoma. Expert Rev Anticancer Ther 6(4):493–506

    Article  PubMed  Google Scholar 

  26. Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, Schachat AP, Straatsma BR, Collaborative Ocular Melanoma Study Group (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 119(7):969–982

    Article  CAS  PubMed  Google Scholar 

  27. Verschueren KM, Creutzberg CL, Schalij-Delfos NE, Ketelaars M, Klijsen FL, Haeseker BI, Ligtenberg SM, Keunen JE, Marijnen CA (2010) Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma. Radiother Oncol 95(3):332–338

    Article  PubMed  Google Scholar 

  28. Shields CL, Shields JA (2009) Ocular melanoma: relatively rare but requiring respect. Clin Dermatol 27(1):122–133

    Article  PubMed  Google Scholar 

  29. Damato B, Coupland SE (2009) An audit of conjunctival melanoma treatment in Liverpool. Eye (Lond) 23(4):801–809

    Article  CAS  Google Scholar 

  30. Walsh-Conway N, Conway RM (2009) Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion. Clin Experiment Ophthalmol 37(6):577–583

    Article  PubMed  Google Scholar 

  31. Finger PT (2009) Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects. Surv Ophthalmol 54(5):545–568

    Article  PubMed  Google Scholar 

  32. Hodi FS, O’Day SJ, McDermott DF et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363(8):711–723

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O’Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361(2):123–134

    Article  CAS  PubMed  Google Scholar 

  34. Krawczyk PM, Eppink B, Essers J, Stap J, Rodermond H, Odijk H, Zelensky A, van Bree C, Stalpers LJ, Buist MR, Soullié T, Rens J, Verhagen HJ, O’Connor MJ, Franken NA, Ten Hagen TL, Kanaar R, Aten JA (2011) Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci U S A 108N:9851–9856

    Article  Google Scholar 

  35. UICC-WHO International Union Against Cancer (2010) TNM Classification of malignant tumours. In: Sobin LH, Gospodarowicz MK, Wittekind C (eds) Melanoma of the skin, 7th edn. Springer, Berlin, pp 172–176

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lukas J. A. Stalpers .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stalpers, L.J.A., Hulshof, M.C.C.M. (2015). Cutaneous Melanoma. In: Panizzon, R., Seegenschmiedt, M. (eds) Radiation Treatment and Radiation Reactions in Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44826-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-44826-7_13

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-44825-0

  • Online ISBN: 978-3-662-44826-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics